Risedronate and hepatic function abnormal Patient Reports February 12, 2012

Risedronate Side Effects Report #5353152-3
Risedronate side effect was reported by a Physician from JAPAN on May 23, 2007. Male patient, 76 years of age, was diagnosed with osteoporosis , musculoskeletal pain and was treated with Risedronate. After drug was administered, patient experienced the following side effects: hepatic function abnormal, lymphocyte stimulation test positive. Risedronate dosage: unknown. During the same period patient was treated with RHEUMATREX, LIPOVAS. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5954623-9
Risedronate side effect was reported by a Physician from JAPAN on Oct 27, 2008. Female patient, 72 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood lactate dehydrogenase increased, blood urea increased, gamma-glutamyltransferase increased, hepatic function abnormal, hypersensitivity. Risedronate dosage: 2.5 MG ONCE DAILY, ORAL. During the same period patient was treated with VOLTAREN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5140802-X
Risedronate side effect was reported by a Physician from JAPAN on Oct 19, 2006. Female patient, 71 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood cholinesterase increased, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with PENFILL R. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5400554-2
Risedronate side effect was reported by a Physician from JAPAN on July 09, 2007. Female patient, 67 years of age, was diagnosed with osteoporosis , hypertension, hyperlipidaemia, gastritis and was treated with Risedronate. After drug was administered, patient experienced the following side effects: autoimmune hepatitis, basophil percentage decreased, haematocrit decreased, haemoglobin decreased, hepatic function abnormal, monocyte percentage increased, red blood cell count decreased. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with BLOPRESS, LIPITOR, STOGAR, ALFAROL. Patient was hospitalized. Patient recovered.


Risedronate Side Effects Report #4621086-5
Risedronate side effect was reported by a Physician from on Mar 14, 2005. Female patient, 64 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with VITAMIN D3, URSODIOL, MEVALOTIN. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5252864-X
Risedronate side effect was reported by a Physician from JAPAN on Feb 14, 2007. Female patient was treated with Risedronate. After drug was administered, patient experienced the following side effects: hepatic function abnormal, jaundice . Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with ONEALFA, IBRUPROFEN. Patient recovered.